Irreversible cochlear damage in myasthenia gravis - Otoacoustic emission analysis

Acta Neurologica Scandinavica

Volumn 113, Issue 1, 2006, Pages 46-54

  Hamed, S A ^a,b   Elattar, A M ^a   Hamed, E A ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b Saudi German Hospital   (Saudi Arabia)

Author keywords

Cochlea; Myasthenia gravis; Nicotinic acetylcholine receptors; Otoacoustic emissions

Indexed keywords

ACETYLCHOLINE; AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; NEUROTRANSMITTER;

ADULT; AMPLITUDE MODULATION; ARTICLE; AUDIOLOGY; AUDITORY NERVOUS SYSTEM; CLINICAL ARTICLE; COCHLEA INJURY; CONTROLLED STUDY; DISEASE COURSE; DISTORTION PRODUCT OTOACOUSTIC EMISSION; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AUDITORY THRESHOLD; CHRONIC DISEASE; COCHLEA; DIAGNOSTIC TECHNIQUES, OTOLOGICAL; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PROSPECTIVE STUDIES;

EID: 33645229460     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00541.x     Document Type: Article

References (42)

1. A ltschuler RA F ex J Efferent neurotransmitters In Altschuler RA Hoffman DW Bobbin RP eds Neurobiology of hearing. The cochlea New York Raven Press 1986 383 96
2. G uth PS N orris CH The hair cell acetylcholine receptors: a synthesis Hear Res 1996 98 1 8
3. F uchs P The synaptic physiology of cochlear hair cells Audiol Neurootol 2002 7 40 4
4. V etter DE L iberman MC M ann J et al. Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation Neuron 1999 23 93 103
5. P opa R A nniko M A rnold W O estreicher E Alpha and beta subunits of acetylcholine receptors in the human inner ear Acta Otolaryngol 2000 120 484 9
6. S ilva A Y sunza A Effect of contralateral masking on the latency of otoacoustic emissions elicited by acoustic distortion products Int J Pediatr Otorhinolaryngol 1998 44 125 32
7. P aludetti G D i N ardo W D'E cclesia A et al. The role of cholinergic transmission in outer hair cell functioning evaluated by distortion product otoacoustic emissions in myasthenic patients Acta Otolaryngol 2001 121 119 21
8. S iegel JH K im DO M olnar CE Effects of altering organ of Corti on cochlear distorsion products f2-f1 and 2f1-f2 J Neurophysiol 1982 7 303 28
9. L onsbury -M artin BL M artin GK The clinical utility of distortion product otoacoustic emissions Ear Hear 1990 11 144 54
10. K akigi A H irakawa H M ount RJ H arrison RV The effects of crossed olivocochlear bundle section on transient evoked otoacoustic emissions Hear Res 1997 110 34 8
11. R eyes S D ing D S un W S alvi R Effect of inner and outer hair cell lesions on electrically evoked otoacoustic emissions Hear Res 2001 158 139 50
12. K omazec Z M ilosevic D F ilipovic D D ankuc D Otoacoustic emissions - a step closer to understanding cochlear function Med Pregl 2001 51 539 42
13. V elenovsky DS G lattke TJ The effect of noise bandwidth on the contralateral suppression of transient evoked otoacoustic emissions Hear Res 2002 164 39 48
14. T oth L R acz T D ioszeghy P R epassy G L ampe I Otoacoustic emission in myasthenia gravis patients and the role of efferent activation Hear Res 1998 126 123 5
15. D i G irolamo S d' E cclesia A Q uaranta N G arozzo A E voli A P aludetti G Effects of contralateral white noise stimulation on distortion product otoacoustic emissions in myasthenic patients Hear Res 2001 162 80 4
16. K urtzke JK K urland LT Epidemiology of neurologic diseases In Baker AB Baker LH eds Clinical neurology Philadelphia Harper and Row 1982 47 9
17. D rachman DB Myasthenia gravis N Engl Med 1994 330 1797 810
18. H ohlfeld R W ekerle H The thymus in myasthenia gravis Neurol Clin 1994 12 331 42
19. S orensen T H olm E-B Myasthenia gravis in the country of Viborg, Denmark Eur Neurol 1989 29 177 9
20. O osterhuis HJ The natural course of myasthenia gravis J Neurol Neurosurg Psychiatry 1989 52 1121 7
21. O sserman KE ed Myasthenia gravis New York Grune and Stratton 1958 80
22. E ngel AG Disturbances in neuromuscular transmission In Engel AG Franzini-Armstrong C eds Myology 2nd edn Columbus McGraw-Hill 1994 2 1769 97
23. Howard JF J r S anders DB M assey JM The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome Neurol Clin 1994 12 305 30
24. S anders DB S coppetta C The treatment of patients with myasthenia gravis Neurol Clin 1994 12 343 68
25. S hah A L isak RP Immunopharmacologic therapy in myasthenia gravis Clin Neuropharmacol 1993 16 97 103
26. D au PC Response to plasmapheresis and immunosuppressive drug therapy in 60 myasthenia gravis patients Ann N Y Acad Sci 1981 337 700 8
27. A ntozzi C G emma M R egi B et al. Short plasma exchange protocol is effective in severe myasthenia gravis J Neurol 1991 238 103 7
28. M orosetti M M eloni C T accone G allucci M et al. Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome ASAIO J 1994 40 638 42
29. V ernino S C heshire WP L ennon VA Myasthenia gravis with autoimmune autonomic neuropathy Auton Neurosci 2001 88 187 92
30. P robst R H auser R Distortion product otoacoustic emissions in normal and hearing impaired ears Am J Otolaryngol 1990 11 236 43
31. S oliman SH Speech discrimination audiometry using Arabic Phonetically Balanced words Aim Shams Med Congr 1976 1 27 30
32. S ilman S G elfand S The acoustic reflex in diagnostic audiology Audiology 1982 7 111 24
33. Elwany S el G arf A K amel T Hearing and middle ear function in rheumatoid arthritis J Rheumatol 1986 13 878 81
34. American National Standards Institute Methods for manual pure-tone threshhold audiometry New York: American National Standards Institute: ANSI 1997;S3.21-1978 (R 1997)
35. S isto R M oleti A Modeling otoacoustic emissions by active nonlinear oscillators J Acoust Soc Am 1999 106 1893 906
36. P robst R H arris EP Transiently evoked and distortion product otoacoustic emissions. Comparison of results from normally hearing and hearing impaired human ears Arch Otolaryngol Head Neck Surg 1993 19 858 60
37. L onsbury -M artin BL M artin GK W hite-head ML Distortion product otoacoustic emissions In Robinette MS Glattke TJ eds Otoacoustic emissions. Clinical applications New York Thieme 1997 83 109
38. R obinette MS G lattke TJ Otoacoustic emissions In Roeser RJ Valente M Hosford-Dunn H eds Audiology diagnosis New York Thieme 2000 503 30
39. K emp DT R yan S B ray P A guide to the effective use of otoacoustic emissions Ear Hear 1990 11 93 105
40. X ue X Z hong N A study on the correlation between distortion product otoacoustic emissions and transient evoked otoacoustic emissions Lin Chuang Er Bi Yan Hou Ke Za Zhi 2003 17 198 200
41. W atanabe S S himazu K T amura N et al. Central acetylcholine receptor function in patients with myasthenia gravis Rinsho Shinkeigaku 1991 31 170 4
42. G lennie MJ S tevenson GT Univalent antibodies kill tumor cells in vitro and in vivo Nature 1982 295 712 4